Molecular Partners Competitors and Similar CompaniesClear all
Molecular Partners's competitors and similar companies include Thor Medical and Abliva.
 Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | |
Founding Date | Founding Date 2004 | Founding Date 2009 | Founding Date 2000 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB | Locations Lund, SE HQ |
Employees | Employees 158 | Employees 3716% decrease | Employees 950% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr439k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit kr4.3m (FY, 2025) | Gross profit kr497k (FY, 2024) |
Net income | Net income (CHF61.7m) (FY, 2025) | Net income (kr58m) (FY, 2025) | Net income (kr90m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Thor Medical
HQ
Oslo, NO
Employees
37↓ 16% decrease
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View companyAbliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View company